If you are considering blepharoplasty and your skin falls in the Fitzpatrick IV-VI range, most online patient guides were written as though you do not exist. Standard content warns about keloids in a way that overstates risk in the wrong location, then stops there. This guide separates the two distinct healing risks that actually apply to your skin type, explains why certain anatomical features common in Black and Hispanic patients force technique changes, and walks through the protocol that surgeons experienced in this population use from the first preoperative appointment through final scar maturation.
Who This Article Is For - And Why South Florida Makes It Especially Relevant
The Fitzpatrick scale classifies skin into six types based on melanin content and response to UV exposure. Types I and II are very fair, burning easily without tanning. Types III and IV cover olive to medium brown. Types V and VI describe dark brown to deeply pigmented skin. The majority of published blepharoplasty outcome literature - and most technique guides - still treat Types I-III as the implicit default patient.
- Fitzpatrick I-II: Fair to light skin with minimal melanin - relatively uncommon in South Florida practices
- Fitzpatrick III-IV: Olive to medium brown, common among Hispanic patients throughout the region
- Fitzpatrick V-VI: Dark brown to deeply pigmented - most Black and Afro-Caribbean patients, and many Afro-Latino patients
US Census Bureau 2025 estimates put Miami-Dade County at 70.6% Hispanic/Latino and 15.3% Black. Broward County, immediately to the north, is 35.0% Hispanic/Latino and 29.1% Black. The combined result is that the majority of blepharoplasty patients in this region carry Fitzpatrick III or higher skin. Ethnic considerations are not a footnote in this context - they are a core surgical topic for virtually every practice in the area, and patients deserve access to the same level of specificity that surgeons discuss in textbooks but rarely publish where patients can find it.

Separating the Keloid Myth from the PIH Reality
Two risks come up whenever darker skin and surgery are discussed together: keloid formation and post-inflammatory hyperpigmentation. They are not the same thing, they do not behave the same way, and conflating them gives patients a fundamentally inaccurate picture of what they are actually facing.
Keloids are abnormal scars that grow beyond the original wound boundary, often months after apparent healing. People of African descent are estimated to be up to 15 times more likely to develop keloids than lighter-skinned individuals of European descent; elevated keloid risk compared to European-descent populations is also documented in people of Hispanic and Asian heritage, though the magnitude of that elevated risk varies across these groups and is generally reported as lower than for African descent. But wherever the risk applies, it is concentrated on the chest, shoulders, and upper back, where dermal tension and sebaceous gland density are high. The thin, low-tension skin of the eyelid is a different tissue environment. A systematic review of eyelid surgery outcomes found hypertrophic scarring in approximately 1 in 100 blepharoplasty cases and no confirmed keloid formations at the eyelid incision site. Presenting keloid risk to eyelid patients without that anatomical context creates fear that has steered real patients away from surgery they would have benefited from.
Post-inflammatory hyperpigmentation - not keloid formation - is the dominant scar-related risk in blepharoplasty for Fitzpatrick IV-VI patients, and it is primarily a pigmentation problem, not a structural one.
Post-inflammatory hyperpigmentation (PIH) is what actually requires a plan. When melanin-rich skin responds to any inflammatory trigger - incision, bruising, sun exposure - melanocytes can overproduce pigment at that site for months. A 2026 prospective scar maturation study tracked pigmentation outcomes at 12 months and found favorable results in 78% of Fitzpatrick I-II patients, 58% of Fitzpatrick III-IV patients, and only 30% of Fitzpatrick V-VI patients. That gap is clinically significant, but it is an argument for a specific protocol - not for avoiding surgery.
A 2026 study in Aesthetic Plastic Surgery used the Vancouver Scar Scale to grade upper blepharoplasty scars across Fitzpatrick types II-V on four criteria: pigmentation, vascularity, pliability, and height. Type V patients had significantly higher total scores. The critical detail is that the difference was driven entirely by pigmentation - vascularity, pliability, and height showed no significant difference between groups. The scar is not thicker, not more raised, and not less supple. It is darker. That is a very different problem - one that responds to topical and behavioral management, not surgical revision.
How Melanin-Rich Skin Ages and Heals Differently
Fitzpatrick IV-VI skin has a thicker, more compacted dermis than lighter skin, with melanocytes that are both more numerous and more reactive. The practical effect is well documented: photoaging and fine wrinkling appear significantly later in life for most Black and many Hispanic patients compared to fair-skinned counterparts. The dermis holds up well under decades of UV exposure.
The flip side of that melanocyte reactivity is that any inflammatory stimulus - surgical incision, bruising, thermal energy from instruments - can trigger melanocyte overproduction at the wound site. The result is a darkened line along the incision that is not a structural scar but can be equally visible. This response does not indicate poor healing. It indicates a melanocyte-rich dermis doing what melanocytes do when provoked. The protocol to manage it treats the cause at the cellular level rather than waiting for the discoloration to resolve on its own.

Anatomical Differences That Change the Operation
Pigmentation management is only part of the picture. Several anatomical features are more prevalent in patients of African, Caribbean, and to some extent Hispanic descent, and each one changes how a surgeon should approach the case.
Eyelid Crease Height
Eyelid crease characteristics differ significantly between Black and Caucasian patients, and individual variation within populations is substantial. In many Black and Afro-Caribbean patients, periorbital tissues are fuller and the crease may be less defined or positioned differently relative to Caucasian norms - check with your surgeon about how your specific anatomy compares. Placing the incision at the height a surgeon might default to for a lighter-skinned patient risks creating an artificially high, Westernized crease that sits in visual conflict with the patient's facial structure. An anthropometric study published in Plastic and Reconstructive Surgery found that African American men have greater pretarsal skin show and higher supratarsal crease height than Caucasian men at baseline, and that these features increase with age in African American but not in Caucasian men. Age-related changes in eyelid anatomy track differently by ethnicity, which affects both how the aging lid is assessed preoperatively and where the incision is placed.
Orbital Vector and Globe Prominence
Some patients of African and Afro-Caribbean descent have genetically prominent globes relative to the cheekbone, an anatomy called a negative orbital vector. In a patient with this feature, reducing upper eyelid fat during blepharoplasty can make the eye appear more prominent after surgery rather than refreshed. A preoperative evaluation that skips orbital vector assessment may produce a technically clean result that the patient finds worse than their starting point. Surgeons experienced with this population assess orbital vector as a standard part of preoperative planning and modify fat management accordingly.
Malar Features and Infraorbital Fat
Malar festoons - loose, fluid-retaining tissue at the lower lid and cheek junction - and prominent infraorbital fat pads are anatomical features that surgeons experienced with Black and Caribbean patients frequently need to identify preoperatively, as their presence affects surgical planning and outcome expectations. Standard lower blepharoplasty does not address either. A patient expecting their under-eye concerns to be resolved by standard lower lid surgery may be disappointed if the surgeon has not flagged these features preoperatively and discussed realistic outcomes or adjunctive approaches.
What a thorough preoperative evaluation must assess in Fitzpatrick IV-VI patients:
- Natural crease position and pretarsal show - to place incisions that preserve ethnic features rather than override them
- Orbital vector - to determine whether fat reduction will help or worsen globe prominence
- Presence of malar festoons or prominent infraorbital fat - conditions standard blepharoplasty does not resolve
- Fitzpatrick skin type - to establish the PIH protocol and scar care plan before the first incision
- Prior keloid history elsewhere on the body - context that informs healing expectations even though eyelid keloids are rare
Upper Blepharoplasty: Technique Modifications That Matter
Incision Placement and Conservative Excision
The incision is placed at the natural crease height for that patient, mapped to their anatomy rather than a default measurement. For Black patients this means placement is determined by individual assessment rather than applying a standard Caucasian reference point. Conservative skin excision - removing less rather than more - is critical. Over-removing skin in Black or Hispanic patients creates a hollowed, over-operated appearance that sits in visual tension with the fuller, rounder facial structure common in these populations, and there is very little a surgeon can do to reverse it. The same conservatism applies to orbicularis muscle removal: most experienced surgeons preserve the orbicularis in Fitzpatrick IV-VI patients to maintain the natural periorbital contour and prevent a skeletonized look.
Cold Steel Over CO2 Laser
Fat reduction, when performed, should be tailored rather than aggressive. In patients with negative orbital vector, orbital fat removal should be minimal or avoided. The goal is a natural refresh of the patient's existing features - not a redesign toward a different facial type.
Lower Blepharoplasty: The Case for Transconjunctival
The transconjunctival approach places the incision on the inner surface of the lower eyelid, completely hidden from outside view. Because there is no external incision, there is no external trigger for post-inflammatory hyperpigmentation. For Fitzpatrick IV-VI patients, this is the preferred route in the large majority of lower blepharoplasty cases.
| Factor | Transconjunctival | External (subciliary) |
|---|---|---|
| External scar | None | Incision just below lash line |
| PIH risk (Fitzpatrick IV-VI) | Eliminated at skin surface | Significant - incision in high-melanocyte area |
| Fat access | Full access for removal or repositioning | Full access |
| Skin redundancy | Not directly addressed | Loose skin can be removed directly |
| Preferred for Fitzpatrick IV-VI | Yes - first choice in most cases | Only when skin removal is necessary and no alternative exists |
When a patient has lower lid skin excess that genuinely requires direct excision, an external incision becomes necessary. In that situation, all the same conservative principles apply: minimal skin removal, cold steel incision, and the full postoperative pigmentation protocol. Fat repositioning - moving native fat from the lower lid pad over the orbital rim to fill the tear trough - is often preferable to removal for Black and Hispanic patients, since aggressive fat removal can create hollowing in faces with more prominent malar structure.
The Pigmentation Protocol: Before and After Surgery
Managing melanocyte response to surgical injury does not start the morning of the operation. The protocol runs for months, and starting before surgery consistently produces better outcomes than beginning after. The underlying logic is consistent throughout: blunt melanocyte activity before the inflammatory stimulus, reduce the stimulus itself through technique choices, then continue suppression during the healing phase when melanocytes are most reactive.
- Begin topical tyrosinase inhibitors 2-4 weeks before surgery. Tyrosinase drives melanin synthesis. Inhibitors including hydroquinone, kojic acid, azelaic acid, and arbutin all work at this enzyme level. The specific agent and concentration are set by the surgeon or a collaborating dermatologist based on skin type and tolerance.
- Stop the inhibitors one to two days before surgery - open skin should not have topical agents on it at the time of incision.
- Avoid all UV exposure for a minimum of 6-8 weeks post-operatively. UV radiation directly stimulates melanocyte activity in healing tissue, and exposure during this window worsens incision-line pigmentation. Physical barrier sunscreen - zinc oxide or titanium dioxide - is preferred near healing eyelid skin over chemical sunscreen formulations.
- Resume topical tyrosinase inhibitors once incisions have closed and healed, typically around week 4-6 post-op, with timing confirmed at a follow-up visit.
- Continue the inhibitor regimen through scar maturation, which in Fitzpatrick V-VI skin can extend to 12 months or more after the operation.
Scar Care and What to Expect During Recovery
The scar at an upper blepharoplasty incision sits within the natural eyelid fold when the eye is open. During the first 4-8 weeks it will be pink to red and may appear darker than surrounding skin in Fitzpatrick IV-VI patients - this is expected, not a sign of a problem. Full scar maturation takes considerably longer in darker skin types than in lighter ones.
Silicone gel sheeting applied to the closed incision site for approximately 12 hours per day, starting at 6-8 weeks post-op, has Level I evidence for reducing hypertrophic scarring. For Fitzpatrick IV-VI patients, this step is an especially important part of the recovery protocol. Silicone creates an occlusive microenvironment that reduces fibroblast activity and helps keep the scar flat and narrow. Sheet form is preferred over silicone creams for the eyelid and can be trimmed to fit the narrow incision area precisely.
Signs that warrant contacting the surgical team:
- A scar that is raised, firm, and growing rather than flat and gradually fading - particularly any extension beyond the incision boundary, which may indicate early hypertrophic change requiring treatment
- Increasing rather than decreasing redness past 8-10 weeks post-op
- Persistent discomfort or tightness beyond the expected early recovery window
- Marked asymmetry in healing between the two eyes
Hyperpigmentation at the incision in the first several months is an expected finding in this skin type, not a complication. Following the protocol - sun avoidance, tyrosinase inhibitors, silicone sheeting - matters more than any single product.
Choosing the Right Surgeon
Board certification in plastic surgery or oculoplastic surgery is a baseline requirement, not a differentiator. What actually distinguishes surgeons for Fitzpatrick IV-VI patients is documented experience with darker skin and the specific anatomical considerations it involves. The American Society of Plastic Surgeons and the American Society of Oculoplastic and Reconstructive Surgery both maintain member directories where certification and specialty training can be verified.
Direct questions to ask in consultation:
- What proportion of your blepharoplasty patients have darker skin? Can I see before-and-after photographs of patients with skin tone similar to mine - ideally at six and twelve months post-op, not just immediately after surgery?
- How do you adjust crease placement for Black patients, and how do you assess for negative orbital vector before deciding on fat management?
- What is your protocol for managing post-inflammatory hyperpigmentation - what do you prescribe before surgery and when do you have patients resume it after?
- Do you use a cold steel scalpel for the incision? What is your position on CO2 laser for this skin type?
- How does your approach to skin and fat excision volume differ for Black and Hispanic patients compared to your general patient population?
Red flags: a surgeon who does not distinguish crease placement by ethnicity, does not raise PIH as a central discussion point, shows before-and-after galleries populated exclusively by lighter-skinned patients, or uses laser incision routinely regardless of skin type. When reviewing photographs of patients with skin similar to yours, well-managed results at 12 months should show natural crease position, no periorbital hollowing, and an incision line trending toward the surrounding skin tone rather than remaining a visible dark line.
Frequently Asked Questions
Am I at high risk for a keloid from blepharoplasty because I am Black?
Your elevated lifetime keloid risk is real, but concentrated on high-tension body areas like the chest and shoulders - not the thin, low-tension skin of the eyelid. A systematic review of eyelid surgery outcomes found no confirmed keloid formations at blepharoplasty incision sites. Post-inflammatory hyperpigmentation is the healing risk that actually applies at this location, and it is managed through a specific pre- and post-operative protocol rather than by avoiding surgery.
Will surgery create an unnatural crease that changes how my eyes look?
It can - if the surgeon places the incision using default measurements calibrated to Caucasian anatomy rather than mapping the natural crease for your individual anatomy. Crease characteristics and position vary among Black and Afro-Caribbean patients and differ from Caucasian norms in ways that require individual assessment, and placing the incision too high creates an artificial Westernized appearance. This is a specific question to raise in consultation, and before-and-after photos of patients with similar anatomy are the most direct way to evaluate how a surgeon handles it in practice.
Can I have lower blepharoplasty without a visible scar on my skin?
In most cases, yes. The transconjunctival approach places the entire incision inside the lower eyelid, leaving no external scar and eliminating any external trigger for post-inflammatory hyperpigmentation. It allows full access to lower lid fat for removal or repositioning. When significant skin excess must also be corrected, a small external incision becomes necessary - but this is a less common scenario and requires the full PIH protocol.
How long does post-inflammatory hyperpigmentation take to fade after surgery?
In Fitzpatrick V-VI patients, full scar maturation takes 12 months or more. A 2026 prospective study found favorable pigmentation outcomes at 12 months in only 30% of Fitzpatrick V-VI patients compared to 78% of Fitzpatrick I-II patients. That is not a reason to avoid surgery - it is the reason the tyrosinase inhibitor protocol, sun avoidance, and silicone sheeting all matter, and why starting the inhibitors before surgery produces better outcomes than beginning after.
What is a tyrosinase inhibitor and why does it matter for surgical healing?
Tyrosinase is the enzyme that drives melanin production in skin cells. Inhibitors including hydroquinone, kojic acid, azelaic acid, and arbutin slow down melanin synthesis at the wound site, reducing the degree and duration of hyperpigmentation that develops during healing. Starting them before surgery primes the skin for a reduced melanocyte response - resuming them once incisions have healed continues suppression during the most reactive phase of scar formation. They do not eliminate PIH entirely, but they significantly reduce its intensity and the time it takes to resolve.
General information only, not medical advice. Individual anatomy and healing vary. See the disclaimer.